started · updated
Missouri AG joins 20 states warning of Chinese drug supply risks
Missouri Attorney General Catherine Hanaway has joined a coalition of 20 state attorneys general in a letter to Secretary of State Marco Rubio, warning of national security and drug safety risks involving Chinese-sourced pharmaceutical suppliers.
The coalition alleges that gaps in federal oversight are being exploited by Chinese businesses to introduce unapproved or knockoff products into the U.S. pharmaceutical supply chain. Specifically, the letter highlights concerns regarding ingredients used in popular compounded GLP-1 drugs, such as semaglutide, tirzepatide, and retatrutide.
The attorneys general contend that the FDA’s “Green List” of authorized suppliers has inadvertently become a channel for suppliers outside the program to ship unapproved products to the United States without proper detention or inspection. The coalition cited Harbin Jixianglong Biotech Co., Ltd. as an example of a company involved in purchasing knockoff semaglutide.
Entities
Catherine Hanaway · China · Food and Drug Administration · Marco Rubio · Missouri Attorney General's Office